CRISPR/Cas9 Essential Gene Editing in Drosophila

Cover Page

Cite item

Abstract

Since the addition of the CRISPR/Cas9 technology to the genetic engineering toolbox, the problems of low efficiency and off-target effects hamper its widespread use in all fields of life sciences. Furthermore, essential gene knockout usually results in failure and it is often not obvious whether the gene of interest is an essential one. Here, we report on a new strategy to improve the CRISPR/Cas9 genome editing, which is based on the idea that editing efficiency is tightly linked to how essential the gene to be modified is. The more essential the gene, the less the efficiency of the editing and the larger the number of off-targets, due to the survivorship bias. Considering this, we generated deletions of three essential genes in Drosophila: trf2, top2, and mep-1, using fly strains with previous target gene overexpression (“pre-rescued” genetic background).

Full Text

ABBREVIATIONS
gRNA – guide RNA
chr – chromosome
kb – kilobase
TRF2 – TBP-related factor 2
Top2 – type II topoisomerase
MEP-1 – MOG interacting and ectopic P-granules protein 1

INTRODUCTION

Recent advances in the use of CRISPR/Cas9 as a programmable tool for the introduction of DNA double-strand breaks significantly expanded possibilities in deciphering the functions of genes and genomic regulatory elements. The CRISPR/Cas9 system is the most suitable for knocking out a gene of interest (GOI) by generating shifts in the reading frame of the target gene. However, if the GOI is an essential one, attempts to generate a knock-out can be ineffective due to lethality in successfully edited embryos, biological plasticity that rescues the induced frameshift or deletion by translation reinitiation, defective exon skipping, etc. [1]. Here, we report on a case of CRISPR/Cas9 use, in combination with target gene overexpression, that allowed us to quite effectively knock out three essential genes in Drosophila. A similar approach has recently been validated in human HEK293T cells [2]. By using this approach, we deleted a relatively long region of the GOI coding sequence and replaced it with a landing platform, which allows for fast and effective insertion of modified gene constructs.

EXPERIMENTAL

 

Fig. 1. The strategy for essential gene replacement. (A) Insertion of a gene copy lacking targets for Cas9 and reporter gene 1 (yellow) into a “safe harbor” knock-in site on a different chromosome via site-specific recombinase-mediated in- tegration (SSRMI). (B) Microinjection of an HDR template and plasmids expressing Cas9 and gRNAs into “pre-rescued” embryos. (C) CRISPR/Cas9-mediated DNA double-strand breaks and homologous recombination (HR) with the plasmid template carrying loxP-flanked reporter gene 2 (mCherry) and an attP site. (D) The result of subsequent SSRMI of the modified gene of interest (GOI) sequence followed by CRE-mediated reporter gene 2 (mCherry) and 3 (white) excision and removal of the GOI copy

 

The strategy presented here is an addition to the methods described in [3–5] and suitable for ubiquitously expressed essential genes. Our method consists of three steps (Fig. 1):

  1. Insertion of the GOI copy (lacking CRISPR/Cas9 target sequences) and reporter gene 1 into a “safe harbor” knock-in site located on a different chromosome. This step results in the generation of the rescue line with homologous expression of the GOI copy. For this, we have created rescue constructs carrying protein-coding sequences of either TRF2, Top2, or MEP-1 under the control of the Ubi-p63E promoter and the yellow gene as reporter 1. Previously obtained knockouts of these genes were embryonic lethal. The constructs were inserted into either 86Fb (TRF2/Top2) or 38D (MEP-1) chromosomal loci via φC31-mediated site-specific integration.
  2. Replacement of the GOI with the attP site by injection of three plasmids: carrying Cas9 and gRNAs for extensive deletion of the GOI protein-coding sequence and a template plasmid for homology-directed repair (HDR) containing the attP site for the φC31 integrase and reporter gene 2 (mCherry), flanked by loxP This step results in the generation of the GOI knockout line with a GOI copy overexpression background. In this work, the following CRISPR/Cas9 Drosophila strains obtained from The Bloomington Drosophila Stock Center at Indiana University were used: BL54591 (Cas9 under the control of the nanos promoter) and BL58492 (Cas9 under the control of the Actin5C promoter). Alternatively, the Addgene #62209 helper plasmid was added to the injection mixture as a source of Cas9. CRISPR targets were designed using the Optimal Target Finder software (University of Wisconsin) [4] and cloned into the vector based on pCFD4-U6:1_U6:3tandemgRNAs (Addgene #49411). The following gRNAs were used for trf2 deletion: gRNA1 (tcttcgtgcatactcttagc), gRNA2 (tgcttttcgcttcggtgtcc), and gRNA3 (accaagtagctagagactta); the gRNA1/gRNA2 pair leads to deletion of a 6.7 kb genomic fragment; gRNA1/gRNA3 causes deletion of a 1.1 kb fragment. For mep-1, the following gRNAs were used: gRNA1m (acgaacagcagggcgcgcgc), gRNA2m (cagcaagtgacgctggcttg), and gRNA3m (aggggatcttcggcctcgca). They produce 5.6 (gRNA1m/ gRNA2m) and 2 kb (gRNA1m/ gRNA3m) deletions. For top2 deletion, gRNA1t (gttcccagtacagtagcacc) and gRNA2t (tctacggcgtgttcccgctt) producing a 2 kb deletion were used. The flies obtained after injection (F0) were individually mated with y1w1118 flies; potential genome editing events in the progeny (F1) were detected by mCherry fluorescence. The insertion of the landing platform (attP-mCherry) into the genome was confirmed by PCR with primers annealing outside the homology regions used for HDR.
  1. Insertion of a modified GOI variant labelled with loxP-flanked reporter gene 3 (white gene) via site-specific recombination. Flies were injected with a mixture containing two plasmids: a plasmid with a modified gene variant and the attB site, and the φC31 integrase helper plasmid (Addgene #26290). After integration of the modified variant, reporter genes 2 and 3 were removed by crossing with a Cre recombinase-expressing line.

RESULTS AND DISCUSSION

The TRF2 protein is a paralog of the basal transcription factor TBP; its inactivation is associated with embryonic lethality [6, 7].

Previously, we failed to replace the trf2 gene with a landing platform for site-specific integration of modified gene variants despite the use of two different Cas9 sources (Cas9-expressing fly lines and the Cas9-expressing plasmid injected into embryos) and two gRNA combinations [8]. The whole trf2 gene spans approximately 25 kb, while its protein-coding region is roughly 7 kb. The chosen gRNA combinations produced two DNA double-strand breaks at distances of 6.7 and 1.1 kb for deletion and concomitant replacement by the landing platform of the whole protein-coding region or only the start codon-containing region, respectively (Fig. 2A).

The results obtained for the different editing schemes used for trf2 gene replacement are summarized in Table 1.

 

Fig. 2. CRISPR/Cas9- and HDR-mediated gene replace- ment with the attP site and reporter gene mCherry. The genes trf2 (A), mep-1 (B), and top2 (C) and homologous recombination templates for either full-length or partial deletions are presented

d

 

The F0 embryos without background trf2 overexpression were characterized by a low survival rate. In the developing larvae, mCherry reporter fluorescence was observed in tissues in the vicinity of the injection site and throughout the whole embryo. The larvae with the most spread and intense fluorescence died later during development. As a result of mating the surviving F0 flies with the wild-type line, only one fly line with insertion of the landing platform into the intron corresponding to the 5` double-strand break without the deletion of the trf2 coding region was obtained.

In order to overcome the high lethality rate due to trf2 deletion, we generated a fly line with trf2 overexpression by site-specific integration of the trf2 short isoform using a line with the attP at locus 86Fb.

The trf2-overexpressing embryos injected with the gene editing mix had normal viability. As a result, we obtained five fly lines with insertion of the mCherry reporter gene for each of the gRNA combinations, producing 6.6 and 1.1 kb deletions, respectively.

We additionally validated this approach on other genes: mep-1 and top2.

MEP-1 is a protein that facilitates the recruitment of the nucleosome remodeling and histone deacetylation (dNuRD) complex to many gene promoters [9, 10]. It is an important regulator of early development in Drosophila; mep-1 gene inactivation leads to embryonic lethality.

As in the case of trf2, the selected gRNA combinations resulted in two DNA double-strand breaks spaced 5.6 or 2 kb apart for the full-length and start codon region deletions, respectively (Fig. 2B). The results obtained for the different editing schemes used for mep-1 gene replacement are summarized in Table 1.

 

Table 1. Results of plasmid microinjections for the replacement of the trf2, mep-1, and top2 genomic regions with a landing platform

Fly line

Cas9 source

Deletion, bp

Embryos injected

Flies eclosed, F0

mCherry + F1 lines

Off-targets

TRF2

y1w1118

Cas9-expressing plasmid

6700

200

100

54591

Cas9 under nanos promoter

6700

250

140

1

+

58492

Cas9 under Actin5C promoter

6700

200

80

1100

250

120

y1w1118 +

TRF2 overexpression

Cas9-expressing

plasmid

6700

100

80

5

2

1100

100

80

5

2

MEP-1

y1w1118

Cas9-expressing

2000

300

160

5600

150

90

1

y1w1118 +

MEP-1 overexpression

plasmid

5600

240

175

4

TOP2

y1w1118

Cas9-expressing

2053

150

100

y1w1118 +

Top2 overexpression

plasmid

2053

150

80

3

 

Embryos injected with the mixture for mep-1 gene replacement without mep-1 overexpression background had moderate lethality during development. Mating of F0 flies resulted in only one fly line, which had a long gene deletion. Meanwhile, injection of the embryos with background mep-1 overexpression led to the generation of four fly lines with the landing platform. Thus, mep-1 deletion is not completely lethal; however, its overexpression increases the viability of injected embryos and, as a consequence, gene editing effectiveness.

Topoisomerase 2 (Top2) is an enzyme that releases topological tension in the DNA molecule; it contributes to genome stability and participates in key cell processes such as replication, transcription, and recombination [11].

For the replacement of the top2 gene with the landing platform, we designed a pair of gRNAs targeting Cas9 to the loci 2 kb apart from each other located in 5`UTR and exon 3 of top2. The editing plasmid mixture for gene replacement was injected into y1w1118 fly embryos. There were no cases of platform insertion in the progeny of individual matings of F0 with wild type flies. However, editing upon insertion of the Top2 coding sequence in the 86Fb chromosomal locus resulted in three knockout fly lines (Table 1).

The use of Cas9 for genome editing is frequently accompanied by additional unspecified mutations throughout the genome. Since mutations usually manifest themselves through phenotype and/or a change in the survival rate, GOI overexpression on a different chromosome allows one to probe the mutations on the GOI chromosome in a line homozygous for GOI deletion. Therefore, it is possible to select only lines without severe mutations.

The generated fly lines homozygous for Δtrf2, Δmep-1, or Δtop2 deletion were lethal without the additional rescuing copy. This corroborated the essentiality of the edited genes and provided initial evidence of successful gene replacement with the attP-platform. Site-specific integration of a restoring construct (coding for the wild-type gene variant) into the corresponding landing platform line and subsequent removal of the reporter genes led to the recovery of gene function and normal viability of homozygous flies lacking the rescuing copy. Thus, overexpression induced prior to gene editing allowed us to obtain landing platforms for a detailed study of three Drosophila proteins: TRF2, Top2, and Mep-1.

***

This work was supported by the Russian Science Foundation (grant No. 19-74-30026).

×

About the authors

Igor S. Osadchiy

Institute of Gene Biology, Russian Academy of Sciences

Author for correspondence.
Email: untie@mail.ru
Россия, Moscow, 119334

Kamalyan O. Sophia

Institute of Gene Biology, Russian Academy of Sciences

Email: sofya171@gmail.com
Россия, Moscow, 119334

Karina Yu. Tumashova

Institute of Gene Biology, Russian Academy of Sciences

Email: HKarina95@mail.ru
Россия, Moscow, 119334

Pavel G. Georgiev

Institute of Gene Biology, Russian Academy of Sciences

Email: georgiev_p@mail.ru
Россия, Moscow, 119334

Oksana G. Maksimenko

Institute of Gene Biology, Russian Academy of Sciences

Email: maksog@mail.ru
ORCID iD: 0000-0003-3502-0303
Россия, Moscow, 119334

References

  1. Smits A.H., Ziebell F., Joberty G., Zinn N., Mueller W.F., Clauder-Münster S., Eberhard D., Fälth Savitski M., Grandi P., Jakob P., et al. // Nat. Methods. 2019. V. 16. № 11. P. 1087–1093.
  2. Wang B., Wang Z., Wang D., Zhang B., Ong S.G., Li M., Yu W., Wang Y. // J. Biol. Eng. BioMed Central. 2019. V. 13. № 1. P. 35.
  3. Gratz S.J., Ukken F.P., Rubinstein C.D., Thiede G., Donohue L.K., Cummings A.M., O’Connor-Giles K.M. // Genetics. 2014. V. 196. № 4. P. 961–971.
  4. Zolotarev N., Georgiev P., Maksimenko O. // Biotechniques. Future Science. 2019. V. 66. № 4. P. 198–201.
  5. Bischof J., Maeda R.K., Hediger M., Karch F., Basler K. // Proc. Natl. Acad. Sci. USA. 2007. V. 104. № 9. P. 3312–3317.
  6. Kedmi A., Zehavi Y., Glick Y., Orenstein Y., Ideses D., Wachtel C., Doniger T., Waldman Ben-Asher H., Muster N., Thompson J., et al. // Genes Dev. 2014. V. 28. № 19. P. 2163–2174.
  7. Duttke S.H.C. // Trends Biochem. Sci. 2015. V. 40. № 3. P. 127–129.
  8. Osadchiy I.S., Georgiev P.G., Maksimenko O.G. // Dokl. Biochem. Biophys. 2019. V. 486. № 1. P. 224–228.
  9. Reddy B.A., Bajpe P.K., Bassett A., Moshkin Y.M., Kozhevnikova E., Bezstarosti K., Demmers J.A., Travers A.A., Verrijzer C.P. // Mol. Cell. Biol. Am. Soc. Microbiol. 2010. V. 30. № 21. P. 5234–5244.
  10. Kunert N., Wagner E., Murawska M., Klinker H., Kremmer E., Brehm A. // EMBO J. 2009. V. 28. № 5. P. 533–544.
  11. Sutormin D.A., Galivondzhyan A.K., Polkhovskiy A.V., Kamalyan S.O., Severinov K.V., Dubiley S.A. // Acta Naturae. 2021. V. 13. № 1. P. 59–75.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The strategy for essential gene replacement. (A) Insertion of a gene copy lacking targets for Cas9 and reporter gene 1 (yellow) into a “safe harbor” knock-in site on a different chromosome via site-specific recombinase-mediated in- tegration (SSRMI). (B) Microinjection of an HDR template and plasmids expressing Cas9 and gRNAs into “pre-rescued” embryos. (C) CRISPR/Cas9-mediated DNA double-strand breaks and homologous recombination (HR) with the plasmid template carrying loxP-flanked reporter gene 2 (mCherry) and an attP site. (D) The result of subsequent SSRMI of the modified gene of interest (GOI) sequence followed by CRE-mediated reporter gene 2 (mCherry) and 3 (white) excision and removal of the GOI copy

Download (513KB)
3. Fig. 2. CRISPR/Cas9- and HDR-mediated gene replace- ment with the attP site and reporter gene mCherry. The genes trf2 (A), mep-1 (B), and top2 (C) and homologous recombination templates for either full-length or partial deletions are presented

Download (335KB)

Copyright (c) 2023 Osadchiy I.S., Sophia K.O., Tumashova K.Y., Georgiev P.G., Maksimenko O.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies